| ASSET | QUARTER | % RETURN |
|---|---|---|
Marker Therapeutics (MRKR) | Q2 2000 | 3,902,339.02% |
Insmed (INSM) | Q2 2000 | 1,538.35% |
Ribbon Communications (RBBN) | Q2 2000 | 393.36% |
PC Connection (CNXN) | Q2 2000 | 189.83% |
Myriad Genetics (MYGN) | Q2 2000 | 149.13% |
Cemtrex (CETX) | Q2 2000 | 148.76% |
Vertex Pharmaceuticals (VRTX) | Q2 2000 | 119.82% |
Hallador Energy (HNRG) | Q2 2000 | 118.2% |
Novanta (NOVT) | Q2 2000 | 108.53% |
CoreSite Realty (COR) | Q2 2000 | 107.53% |
Pixelworks (PXLW) | Q2 2000 | 102.22% |
Nortech Systems (NSYS) | Q2 2000 | 94.78% |
Vicor (VICR) | Q2 2000 | 92.73% |
Hexcel (HXL) | Q2 2000 | 90% |
DaVita HealthCare Partners (DVA) | Q2 2000 | 88.24% |
Trimble (TRMB) | Q2 2000 | 87.74% |
Quest Diagnostics (DGX) | Q2 2000 | 86.88% |
Bio-Techne (TECH) | Q2 2000 | 85.88% |
Exelixis (EXEL) | Q2 2000 | 85.42% |
Laboratory Corporation of America (LH) | Q2 2000 | 84.18% |
Sangamo Therapeutics (SGMO) | Q2 2000 | 83.78% |
Bloomia (TULP) | Q2 2000 | 83.61% |
3D Systems (DDD) | Q2 2000 | 83.13% |
Plexus (PLXS) | Q2 2000 | 71.21% |
Forward Air (FWRD) | Q2 2000 | 68.42% |